The Potential of Isoprenoids in Adjuvant Cancer Therapy to Reduce Adverse Effects of Statins
The mevalonate pathway provides sterols for membrane structure and nonsterol intermediates for the post-translational modification and membrane anchorage of growth-related proteins, including the Ras, Rac, and Rho GTPase family. Mevalonate-derived products are also essential for the Hedgehog pathway...
Saved in:
Main Authors: | Huanbiao Mo (Author), Rayna Jeter (Author), Andrea Bachmann (Author), Sophie T. Yount (Author), Chwan-Li Shen (Author), Hoda Yeganehjoo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Statin therapy: a potential adjuvant to immunotherapies in hepatocellular carcinoma
by: Jiao Wang, et al.
Published: (2024) -
Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond
by: Alpo Vuorio, et al.
Published: (2021) -
The Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent
by: Javier Frontiñán-Rubio, et al.
Published: (2021) -
Natural statin derivatives as potential therapy to reduce intestinal fluid loss in cholera.
by: Rattikarn Noitem, et al.
Published: (2022) -
Isolation and Characterization of an Acyclic Isoprenoid from Semecarpus anacardium Linn. and its Antibacterial Potential in vitro - Antimicrobial Activity of Semecarpus anacardium Linn. Seeds -
by: Ayyakkannu Purushothaman, et al.
Published: (2017)